REDUCEDT+7
Immunovant Inc · NASDAQ
−85,886 sh · $2.9M
Filed 5 Oct 2026SEC Form 4view source
- REDUCEDT+7
Immunovant Inc · NASDAQ
−3,506 sh · $119.6K
Filed 5 Oct 2026SEC Form 4view source - ACQUIREDT+7
Immunovant Inc · NASDAQ
+92,187 sh · $1.3M
Filed 5 Oct 2026SEC Form 4view source - ACQUIREDStale
Roivant Sciences Ltd · NASDAQ
+200,000 sh · $770.0K
Filed 1 Sept 2026SEC Form 4view source - REDUCEDStale
Roivant Sciences Ltd · NASDAQ
−166,182 sh · $5.9M
Filed 1 Sept 2026SEC Form 4view source - REDUCEDStale
Roivant Sciences Ltd · NASDAQ
−33,818 sh · $1.2M
Filed 1 Sept 2026SEC Form 4view source - REDUCEDStale
Roivant Sciences Ltd · NASDAQ
−13,909 sh · $512.4K
Filed 24 Aug 2026SEC Form 4view source